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1 |  INTRODUCTION
Primary congenital glaucoma (PCG, MIM 231300) is a sig-
nificant cause of irreversible blindness in children and re-
sults from developmental defects of the aqueous humor 
outflow pathway structures. It is characterized by increased 
intraocular pressure (IOP), buphthalmos, optic disc cupping, 
corneal edema, enlarged corneal diameter, and/or Haab's 
striae (Thau et al., 2018). A high incidence has been found 
among some populations with founder effects or a high rate 
of consanguinity (Slovakian Roma 1/1,250 (Gencik, 1989), 
Saudi Arabian 1/2,500 (Bejjani et al., 2000)) but incidence 
is lower in Western countries, including Australia (1/30,000 
births) (MacKinnon, Giubilato, Elder, Craig, & Mackey, 
2004).
PCG is most commonly associated with autosomal re-
cessive variants in CYP1B1 on chromosome 2p21 (MIM 
601771) (Stoilov, Akarsu, & Sarfarazi, 1997). Mice defi-
cient in CYP1B1 have developmental defects of the ocular 
drainage structures resembling those reported in individuals 
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Abstract
Background: CYP1B1 variants and deletions are the most common cause of primary 
congenital glaucoma (PCG).
Methods: We investigated an individual with PCG from the Australian and New 
Zealand Registry of Advanced Glaucoma. We performed sequencing of the CYP1B1 
gene, followed by Multiplex Ligation‐dependent Probe Amplification and SNP array.
Results: We identified a homozygous deletion of the CYP1B1 gene by Multiplex 
Ligation‐dependent Probe Amplification and confirmed that the father was heterozy-
gous for a CYP1B1 deletion but the mother had normal gene copy number. SNP array 
identified paternal uniparental isodisomy of the entire chromosome 2.
Conclusions: This study is the first report of a homozygous CYP1B1 whole gene 
deletion due to paternal uniparental isodisomy of chromosome 2 as a cause of PCG. 
These results illustrate the importance of genetic testing in providing appropriate 
genetic counseling regarding the risks of recurrence.
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with PCG, supporting loss of function as a mechanism of 
CYP1B1 variants causing PCG (Libby et al., 2003). Over 200 
pathogenic sequence variants have been reported in CYP1B1 
(http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CYP1B1), 
however deletions of the gene have seldom been reported 
(Damjanovich, Baldwin, Lewis, & Bayrak‐Toydemir, 2013; 
Kelberman et al., 2011; Milla et al., 2013; Stoilov, et al., 
1997). In this study, we report an individual with PCG and 
a homozygous CYP1B1 deletion arising from paternal unipa-
rental isodisomy of chromosome 2.
2 |  CASE REPORT
The study was conducted in accordance with the revised 
Declaration of Helsinki and participants were recruited 
with the approval of the Southern Adelaide Clinical Human 
Research Ethics Committee. The proband and his family 
members were enrolled as part of The Australian and New 
Zealand Registry of Advanced Glaucoma and gave their 
informed consent (Souzeau et al., 2012). The proband was 
a 15‐year‐old boy and the second child of nonconsanguin-
eous Indian parents. He presented with bilateral significant 
corneal clouding, enlarged cornea 12  mm horizontally and 
raised IOP at birth. Right trabeculectomies were performed 
at 4 weeks and 3 months of age, however this eye became 
densely amblyopic. His better left eye had a trabeculec-
tomy with Mitomycin C antimetabolite at age 32  months. 
Sequential left then right Ahmed tube surgery took place at 
age 4 and 5  years. These surgeries all took place in India. 
His family moved to Australia when he was 11  years. At 
that time his right eye was blind with perception of light, he 
had IOP of 30 mmHg, band keratopathy, a small pupil and 
dense cataract limiting the view of his optic nerve (Figure 
1). The better left eye has nystagmus, vision of 3/15, IOP in 
the mid‐teens on maximal topical medical therapy and since 
age 13 also acetazolamide 250 mg bd. His most recent field 
test had generalized reduced sensitivity, with a left nasal step. 
Both parents and his older sister were examined and were 
unaffected.
3 |  GENETIC ANALYSIS
Genomic DNA was extracted from venous blood of the 
proband, his parents, and his sister. CYP1B1 sequencing 
was performed on the proband's DNA through the NATA 
(National Association of Testing Authorities) accredited 
laboratories of SA Pathology at Flinders Medical Centre 
(Adelaide, Australia) as previously described (Souzeau, 
Hayes, Zhou, et al., 2015). Amplification of the two coding 
exons of CYP1B1 failed, suggesting a potential gene deletion 
(data not shown).
CYP1B1 was then analyzed for copy number variation by 
Multiplex Ligation‐dependent Probe Amplification (MLPA) 
using the SALSA P128 Cytochrome P450 probemix (MRC 
Holland, Amsterdam, The Netherlands) according to the man-
ufacturers' protocol. MLPA analysis of CYP1B1 indicated an 
abnormal copy number in the proband's DNA, characteristic 
of a homozygous deletion of the entire gene. MLPA analysis 
of both parents was then performed, and revealed in the father 
the loss of a single allele of CYP1B1 but indicated a normal 
copy number for all exons of CYP1B1 in the mother (Figure 2).
To investigate the extent of the CYP1B1 gene deletion in 
the proband and the possibility of uniparental disomy (UPD), 
a SNP array (Illumina Infinium CytoSNP‐850K BeadChip) 
was conducted. Array result of the proband revealed an inter-
stitial homozygous deletion of 119kb on chromosome 2q22.2 
(chr2: 38 239 356–38 358 664, GRCh37/hg19 assembly) en-
compassing the entire CYP1B1 gene as well as the RMDN2 
gene (MIM 611872). The RMDN2 gene has not been asso-
ciated with any clinical phenotype. Paternal isodisomy for 
the entire chromosome 2 was identified, confirming that the 
homozygous CYP1B1 deletion in the child originated from 
F I G U R E  1  Slit lamp photographs of the proband. Right eye (RE) showing central calcified band keratopathy, unreactive pupil with surgical 
iridectomy occluded by cataract. Left eye (LE) showing iridectomy (iris resection in the superior part of the iris) from previous trabeculectomy, 
constriction of the pupil due to intraocular lowering topical therapy and limbal scars due to surgery (at the corner of the cornea and the sclera)
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a single parent (Figure 2). Chromosome 2 has not been as-
sessed for the presence of other homozygous variants.
4 |  DISCUSSION
UPD is a rare event that arises when an individual with a dip-
loid genome carries both homologs of a pair of chromosomes 
from one parent (uniparental heterodisomy) or both copies of 
a single parental chromosome (uniparental isodisomy) (Engel, 
1980). UPD can result in clinically recognizable phenotypes 
through imprinting defects, mosaicism, or unmasking of ho-
mozygosity for pathogenic variants inherited from one parent 
in autosomal recessive genes. Paternal UPD2 is relatively rare 
and has generally been reported following genetic analysis of 
individuals homozygous for variants in autosomal recessive 
genes consistent with their phenotype (Baskin, Geraghty, & 
Ray, 2010; Chavez, Valdez, & Vilchis, 2000; Lopez‐Garrido, 
Campos‐Mollo, Harto, & Escribano, 2009; Shen et al., 2018; 
Thompson et al., 2002). One of these cases involved a ho-
mozygous CYP1B1 missense variant due to paternal UPD2 in 
a patient with PCG (Lopez‐Garrido et al., 2009).
F I G U R E  2  Pedigree and genetic analysis. (a) Pedigree of the family. The solid symbol indicates primary congenital glaucoma, the 
CYP1B1 deletion is represented by “Del” and the wild type allele by the “+’ sign. (b) Single nucleotide polymorphism (SNP) array confirming 
the homozygous CYP1B1 deletion (top panel) and B allele frequency plot showing complete homozygosity on chromosome 2, corresponding to 
uniparental isodisomy (bottom panel). The B allele frequency is a normalized measure of the allele frequency ratio of the two alleles: values of 0 
or 1 indicate areas of homozygosity, whereas a value of 0.5 indicates areas of heterozygosity. (c) MLPA analysis showing normal CYP1B1 copy 
number in the proband's mother (upper panel), heterozygous CYP1B1 deletion in the proband's father (middle panel) and homozygous CYP1B1 
deletion in the proband (bottom panel). The arrows show the two probes in exons 1 and 3, while the other peaks represent unrelated probes to other 
genes used as internal controls
(a) (b)
(c)
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We previously showed that deletion of the entire CYP1B1 
gene is not a major contributor to PCG (Souzeau, Hayes, 
Ruddle, et al., 2015). CYP1B1 deletions have only been re-
ported three times, with deletion sizes ranging from 146kb 
to 193kb (Figure 3) (Damjanovich et al., 2013; Kelberman 
et al., 2011; Milla et al., 2013). The deletion reported in 
this study is the smallest deletion encompassing the entire 
CYP1B1 gene, with a size of 119kb. All reported deletions in-
cluded part of the RMDN2 gene that has not been associated 
with any clinical phenotype.
The confirmation of UPD as the cause of variant homozy-
gosity has important implications for the family in terms of 
genetic counseling. The parents can be counseled that the risk 
of recurrence for other children is low, as opposed to the 25% 
risk of recurrence usually reported for variants in autosomal 
recessive genes such as CYP1B1. Similarly, the occurrence of 
phenotypically normal individuals with paternal UPD2 does 
not support a significant role for paternally imprinted genes 
on chromosome 2 (Keller et al., 2009; Ou et al., 2013). This 
is supported by the absence of additional clinical features in 
the proband reported in this study.
In summary, this is the first report of a homozygous 
CYP1B1 whole gene deletion due to paternal UPD2 and as-
sociated with PCG. This study illustrates the importance of 
genetic testing in identifying the underlying molecular cause 
of the disease and in providing adequate genetic counseling 
regarding the possible recurrence risks.
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